Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$268.23+1.89 (+0.71%)
Delayed quote: Sep 11, 2026, 9:30 AM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 11, 2026, 9:30 AM EDT
The latest quarterly buybacks is −$221.00 Million with a QoQ Growth of +94.51%. Share buybacks (stock repurchases) represent cash spent by the company to buy back its own shares in the open market, reducing shares outstanding and returning capital to shareholders.
Q2 FY2026 (2026-06-28).
Reported quarterly buybacks; no daily interpolation. Q2 FY2026 (2026-06-28): $-221.00M.
−$221.00M
−$221.00 Million
Q2 FY2026 · 2026-06-28
+94.51%
vs. −$4.03B prior quarter
96
Quarters of data available
| Period | Buybacks | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-28 | −$221.00M | +94.51% | N/A |
| Q1 FY2026Period end 2026-03-29 | −$4.03B | -109.36% | -89.37% |
| Q4 FY2025Period end 2025-12-28 | −$1.92B | -1.16% | -582.27% |
| Q3 FY2025Period end 2025-09-28 | −$1.90B | N/A | -252.88% |
| Q2 FY2025Period end 2025-06-29 | $0 | N/A | N/A |
| Q1 FY2025Period end 2025-03-30 | −$2.13B | -654.26% | -44.20% |
| Q4 FY2024Period end 2024-12-29 | −$282.00M | +47.68% | -30.56% |
| Q3 FY2024Period end 2024-09-29 | −$539.00M | -296.32% | +41.41% |
| Q2 FY2024Period end 2024-06-30 | −$136.00M | +90.78% | +64.30% |
| Q1 FY2024Period end 2024-03-31 | −$1.48B | -582.87% | +58.30% |
| Q4 FY2023Period end 2023-12-31 | −$216.00M | +76.52% | +83.64% |
| Q3 FY2023Period end 2023-10-01 | −$920.00M | -141.47% | +57.51% |
| Q2 FY2023Period end 2023-07-02 | −$381.00M | +89.23% | +60.84% |
| Q1 FY2023Period end 2023-04-02 | −$3.54B | -167.95% | -124.29% |
| Q4 FY2022Period end 2022-12-31 | −$1.32B | +39.03% | -32.53% |
| Q3 FY2022Period end 2022-10-02 | −$2.17B | -122.51% | -453.71% |
| Q2 FY2022Period end 2022-07-03 | −$973.00M | +38.30% | -54.20% |
| Q1 FY2022Period end 2022-04-03 | −$1.58B | -58.33% | -9.67% |
| Q4 FY2021Period end 2021-12-31 | −$996.00M | -154.73% | -210.28% |
| Q3 FY2021Period end 2021-10-03 | −$391.00M | +38.03% | +19.05% |
| Q2 FY2021Period end 2021-07-04 | −$631.00M | +56.12% | +10.62% |
| Q1 FY2021Period end 2021-04-04 | −$1.44B | -347.98% | +15.96% |
| Q4 FY2020Period end 2020-12-31 | −$321.00M | +33.54% | +24.65% |
| Q3 FY2020Period end 2020-09-27 | −$483.00M | +31.59% | +70.33% |
| Q2 FY2020Period end 2020-06-28 | −$706.00M | +58.74% | +71.60% |
| Q1 FY2020Period end 2020-03-29 | −$1.71B | -301.64% | +22.44% |
| Q4 FY2019Period end 2019-12-31 | −$426.00M | +73.83% | +88.81% |
| Q3 FY2019Period end 2019-09-29 | −$1.63B | +34.51% | -245.65% |
| Q2 FY2019Period end 2019-06-30 | −$2.49B | -12.69% | -1614.48% |
| Q1 FY2019Period end 2019-03-31 | −$2.21B | +42.07% | -52.77% |
| Q4 FY2018Period end 2018-12-31 | −$3.81B | -708.49% | -367.24% |
| Q3 FY2018Period end 2018-09-30 | −$471.00M | -224.83% | -51.45% |
| Q2 FY2018Period end 2018-07-01 | −$145.00M | +89.96% | +92.33% |
| Q1 FY2018Period end 2018-04-01 | −$1.44B | -77.18% | +56.79% |
| Q4 FY2017Period end 2017-12-31 | −$815.00M | -162.06% | +59.75% |
| Q3 FY2017Period end 2017-10-01 | −$311.00M | +83.54% | +85.88% |
| Q2 FY2017Period end 2017-07-02 | −$1.89B | +43.45% | +19.98% |
| Q1 FY2017Period end 2017-04-02 | −$3.34B | -65.04% | -39.89% |
| Q4 FY2016Period end 2016-12-31 | −$2.02B | +8.08% | -6.80% |
| Q3 FY2016Period end 2016-10-02 | −$2.20B | +6.73% | -634.33% |
| Q2 FY2016Period end 2016-07-03 | −$2.36B | +1.13% | -163.62% |
| Q1 FY2016Period end 2016-04-03 | −$2.39B | -26.00% | -8.69% |
| Q4 FY2015Period end 2015-12-31 | −$1.90B | -532.00% | +30.88% |
| Q3 FY2015Period end 2015-09-27 | −$300.00M | +66.52% | +87.58% |
| Q2 FY2015Period end 2015-06-28 | −$896.00M | +59.24% | +24.83% |
| Q1 FY2015Period end 2015-03-29 | −$2.20B | +19.87% | -183.98% |
| Q4 FY2014Period end 2014-12-31 | −$2.74B | -13.58% | -462.09% |
| Q3 FY2014Period end 2014-09-28 | −$2.42B | -102.60% | +20.82% |
| Q2 FY2014Period end 2014-06-29 | −$1.19B | -54.01% | N/A |
| Q1 FY2014Period end 2014-03-30 | −$774.00M | -58.61% | N/A |
| Q4 FY2013Period end 2013-12-31 | −$488.00M | +84.00% | N/A |
| Q3 FY2013Period end 2013-09-29 | −$3.05B | N/A | N/A |
| Q2 FY2013Period end 2013-06-30 | $0 | N/A | N/A |
| Q1 FY2013Period end 2013-03-31 | $0 | N/A | N/A |
| Q4 FY2012Period end 2012-12-31 | $0 | N/A | N/A |
| Q3 FY2012Period end 2012-09-30 | $0 | N/A | N/A |
| Q2 FY2012Period end 2012-07-01 | −$12.85B | N/A | -2501.62% |
| Q1 FY2012Period end 2012-04-01 | −$67.00M | +92.15% | +84.60% |
| Q4 FY2011Period end 2011-12-31 | −$853.00M | -14.80% | +33.62% |
| Q3 FY2011Period end 2011-10-02 | −$743.00M | -50.40% | -1.50% |
| Q2 FY2011Period end 2011-07-03 | −$494.00M | -13.56% | -24.43% |
| Q1 FY2011Period end 2011-04-03 | −$435.00M | +66.15% | -13.58% |
| Q4 FY2010Period end 2010-12-31 | −$1.28B | -75.55% | -34.13% |
| Q3 FY2010Period end 2010-10-03 | −$732.00M | -84.38% | N/A |
| Q2 FY2010Period end 2010-07-04 | −$397.00M | -3.66% | -37.37% |
| Q1 FY2010Period end 2010-04-04 | −$383.00M | +60.02% | +54.08% |
| Q4 FY2009Period end 2009-12-31 | −$958.00M | N/A | -9.11% |
| Q3 FY2009Period end 2009-09-27 | −$49.00M | +83.04% | +97.73% |
| Q2 FY2009Period end 2009-06-28 | −$289.00M | +65.35% | +84.28% |
| Q1 FY2009Period end 2009-03-29 | −$834.00M | +5.01% | +53.12% |
| Q4 FY2008Period end 2008-12-31 | −$878.00M | +59.28% | +70.98% |
| Q3 FY2008Period end 2008-09-28 | −$2.16B | -17.30% | -17.05% |
| Q2 FY2008Period end 2008-06-29 | −$1.84B | -3.32% | -313.96% |
| Q1 FY2008Period end 2008-03-30 | −$1.78B | +41.21% | -503.05% |
| Q4 FY2007Period end 2007-12-31 | −$3.03B | -64.28% | -123.98% |
| Q3 FY2007Period end 2007-09-30 | −$1.84B | -314.86% | +23.35% |
| Q2 FY2007Period end 2007-07-01 | −$444.00M | -50.51% | +82.70% |
| Q1 FY2007Period end 2007-04-01 | −$295.00M | +78.16% | +26.43% |
| Q4 FY2006Period end 2006-12-31 | −$1.35B | +43.78% | -144.30% |
| Q3 FY2006Period end 2006-10-01 | −$2.40B | +6.39% | -1265.34% |
| Q2 FY2006Period end 2006-07-02 | −$2.57B | -540.15% | -668.56% |
| Q1 FY2006Period end 2006-04-02 | −$401.00M | +27.49% | +38.69% |
| Q4 FY2005Period end 2005-12-31 | −$553.00M | -214.20% | -38.60% |
| Q3 FY2005Period end 2005-10-02 | −$176.00M | +47.31% | +21.78% |
| Q2 FY2005Period end 2005-07-03 | −$334.00M | +48.93% | +5.38% |
| Q1 FY2005Period end 2005-04-03 | −$654.00M | -63.91% | -60.69% |
| Q4 FY2004Period end 2004-12-31 | −$399.00M | -77.33% | -64.88% |
| Q3 FY2004Period end 2004-09-26 | −$225.00M | +36.26% | -127.27% |
| Q2 FY2004Period end 2004-06-27 | −$353.00M | +13.27% | +29.82% |
| Q1 FY2004Period end 2004-03-28 | −$407.00M | -68.18% | -20.06% |
| Q4 FY2003Period end 2003-12-31 | −$242.00M | -144.44% | +32.21% |
| Q3 FY2003Period end 2003-09-28 | −$99.00M | +80.32% | +89.31% |
| Q2 FY2003Period end 2003-06-29 | −$503.00M | -48.38% | N/A |
| Q1 FY2003Period end 2003-03-30 | −$339.00M | +5.04% | N/A |
| Q4 FY2002Period end 2002-12-31 | −$357.00M | +61.45% | N/A |
| Q3 FY2002Period end 2002-09-29 | −$926.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.